Zobrazeno 1 - 10
of 732
pro vyhledávání: '"W, Kalow"'
Publikováno v:
Pharmacogenetics. 4:117-124
Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caf
Publikováno v:
Pharmacogenetics. 2:38-45
Acetaminophen (paracetamol) is extensively conjugated with glucuronic acid and sulfate prior to renal excretion. A minor metabolic route involves microsomal oxidation of acetaminophen to a hepatotoxic reactive intermediate, which subsequently undergo
Autor:
M.Y. Bell, W.L. Smith, David F. Andrews, Donald R. McLachlan, Theo P.A. Kruck, A.J. Dalton, W. Kalow
Publikováno v:
The Lancet. 337:1304-1308
Although epidemiological and biochemical evidence suggests that aluminium may be associated with Alzheimer's disease (AD), there is no convincing proof of a causal link for aluminium in disease progression. We have completed a two year, single-blind
Autor:
W. Kalow
Publikováno v:
Ciba Foundation Symposium-Drug Responses in Man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df8df6761e1e9acaf07e13eabc3cdd6
https://doi.org/10.1002/9780470719558.ch13
https://doi.org/10.1002/9780470719558.ch13
Autor:
W. Kalow
Publikováno v:
Life Sciences. 47:1385-1397
Autor:
W. Kalow
Publikováno v:
Molecular Analysis and Genome Discovery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53690b01e46b6757786a00ea749e5beb
https://doi.org/10.1002/0470020202.ch1
https://doi.org/10.1002/0470020202.ch1
Publikováno v:
British journal of clinical pharmacology. 58(7)
Autor:
W, Kalow
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(4 Pt 2)